Emmanuel Paradis is senior researcher in the French Institute of Research for Development (IRD). His research focuses on evolutionary models and their applications. The development and publication of ...
The U.S. Food and Drug Administration (FDA) announced Rare Disease Evidence Principles (RDEP) to allow for faster approval of treatments for ultra-rare genetic diseases. A product is eligible if it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results